Cited by

• Psychosocial Needs of Gynecological Cancer Survivors: Mixed Methods Study.

  Adams EJ, Tallman D, Haynam ML, Nekhlyudov L, Lustberg MB. Adams EJ, et al. J Med Internet Res. 2022 Sep 20;24(9):e37757. doi: 10.2196/37757. J Med Internet Res. 2022. PMID: 36125848 Free PMC article.
• BCR-Net: A deep learning framework to predict breast cancer recurrence from histopathology images.

  Su Z, Niazi MKK, Tavolara TE, Niu S, Tozbikian GH, Wesolowski R, Gurcan MN. Su Z, et al. PLoS One. 2023 Apr 4;18(4):e0283562. doi: 10.1371/journal.pone.0283562. eCollection 2023. PLoS One. 2023. PMID: 37014891 Free PMC article.
• Unsealed¹⁸⁸ Rhenium Resin Brachytherapy in Non-Surgical Candidates With Refractory Basal Cell Carcinoma: Clinical Outcomes.

  Chessa MA, Baraldi C, Savoia F, Maltoni L, Clarizio G, Filippi F, Piraccini B, Dika E, Pitino A, Tripepi G, Zagni F, Strigari L, Vetrone L, Fanti S, Castellucci P. Chessa MA, et al. Dermatol Pract Concept. 2025 Apr 1;15(2):4993. doi: 10.5826/dpc.1502a4933. Dermatol Pract Concept. 2025. PMID: 40401867 Free PMC article.
• Prognostic value of computed tomography derived skeletal muscle mass index in lung cancer: A meta-analysis.

  Pan XL, Li HJ, Li Z, Li ZL. Pan XL, et al. World J Clin Cases. 2022 Jul 16;10(20):6927-6935. doi: 10.12998/wjcc.v10.i20.6927. World J Clin Cases. 2022. PMID: 36051119 Free PMC article.
• Co-expression of cancer stem cell markers, SALL4/ALDH1A1, is associated with tumor aggressiveness and poor survival in patients with serous ovarian carcinoma.

  Sharbatoghli M, Shamshiripour P, Fattahi F, Kalantari E, Habibi Shams Z, Panahi M, Totonchi M, Asadi-Lari Z, Madjd Z, Saeednejad Zanjani L. Sharbatoghli M, et al. J Ovarian Res. 2022 Jan 28;15(1):17. doi: 10.1186/s13048-021-00921-x. J Ovarian Res. 2022. PMID: 35090523 Free PMC article.